Navigation Links
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
Date:9/19/2007

mpared with those who received the traditional flu shot (4.5 percent vs. 9.8 percent, respectively).(1) In the study, FluMist demonstrated a reduction in influenza rates compared to the inactivated vaccine against strains that were both matched and mismatched to the vaccine.

In 48 completed clinical trials, more than 48,000 subjects ranging in age from six weeks to more than 90 years of age received FluMist. In addition to the clinical trial experience, approximately 60,000 doses of FluMist have been administered in two post-marketing studies, and approximately seven million doses of FluMist have been distributed for use in individuals five to 49 years of age following licensure of the product in 2003 through the 2006-2007 influenza season. FluMist is different from the flu shot in that it uses live, attenuated - or weakened - viruses within the vaccine to help stimulate an immune response that is designed to closely resemble the body's natural response to an influenza infection.

"The FDA approval of FluMist for young children is important because these young kids have very high attack rates for influenza, often require medical evaluation for their influenza illness, and can spread influenza easily to others," said Pedro Piedra, M.D., professor, Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine. "Also, the live attenuated influenza vaccine is quite effective in helping prevent influenza and is generally very acceptable to children and their parents since it is administered by nasal spray rather than a shot."

Influenza's Impact on Young Children

The flu is most prevalent in school-age children, as the virus travels easily from person to person and because children in this age group spend a large part of their day in close contact with other children. Children two to 17 years of age are twice as likely to get influenza than adults, including the elderly.(2) During a widespread outbreak, the rate of fl
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. FDA approves Phase 0 trial which tests experimental drugs on humans
2. FDA Approves Contraceptive Ring
3. FDA approves new device to treat womens bleeding disorder
4. FDA Approves New HIV Drug, Viread
5. FDA Approves Birth Control Skin Patch
6. FDA approves surgical gel
7. FDA Approves New Arthritis Drug, Bextra
8. FDA Approves Elidel Cream for Eczema
9. FDA approves drug for rare liver disease
10. FDA approves first pocket-sized EKG machine
11. FDA Approves New Anti-Clotting Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... March 30, 2015 Telerad RxDx ... the coveted NABH Accreditation on 11th January 2015. ... Hospitals and Healthcare Providers) comes as a true ... standards of Telerad RxDx., With Telerad RxDx being ... accredited for NABH, marks a major achievement and ...
(Date:3/29/2015)... Washington, D.C. USA (PRWEB) March 29, 2015 ... Afro Health Link platform provides basic health ... them the opportunity to discuss these challenges as ... them. Afro Health Link addresses six medical conditions ... and encourage users to engage in conversations around ...
(Date:3/28/2015)... Rocket Pure , a manufacturer of natural ... their new natural sunscreen. They are offering the sunscreen ... options come with a bonus lip balm sunscreen. , The ... Click to see the natural sunscreen on Amazon ... is made with non-nano zinc oxide and provides broad-based protection ...
(Date:3/28/2015)... 28, 2015 With more than ... fields of osteoporosis, osteoarthritis and musculoskeletal diseases gathered ... may be the first time in the 17-year ... that the hot-button topic is an emerging non-pharmaceutical ... well-accepted scientific principles of Wolff’s law, osteogenic loading ...
(Date:3/28/2015)... An article in Fortune on Monday, March ... to organizations that deal with PCI (Payment Card Information); ... security, is worsening . Using numbers from Verizon’s ... category out of the twelve measured improved, barring one ... craziness that has gone on in the retail industry ...
Breaking Medicine News(10 mins):Health News:NABH Accreditation for Telerad RxDx – Whitefield. 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 3Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4
... , FRIDAY, Dec. 23 (HealthDay News) -- The holiday ... need to take steps to ensure they stay healthy through ... U.S. adults is a cancer survivor and their ranks are ... to the disease and its treatment, experts at the ...
... American Association of Anatomist,s (AAA) Young Investigator,Awards ... Mossmanwith the recently established Morphological Sciences Award, ... of their careers who have made important ... in cell/molecular biology, developmental biology, comparative neuroanatomy, ...
... The University of Kentucky Markey Cancer Center breast ... findings from their studies on relapse of breast cancer ... The two studies aimed to characterize further risk ... early metastatic relapse after initial therapy. Data for each ...
... By Amanda Gardner HealthDay Reporter , ... a long-simmering controversy, editors at the journal Science ... virus as the likely cause of chronic fatigue syndrome. ... virus-related virus (XMRV) was the probable culprit behind chronic ...
... Alan Mozes HealthDay Reporter , THURSDAY, Dec. ... same without the uplifting sound of holiday choirs, but ... "The Unforgettables," that,s bringing new harmony to singers and ... include 11 men and women diagnosed with early to ...
... factor for lung cancer, but nearly 25% of all lung ... online today in Genome Research ( www.genome.org ), ... could explain a significant proportion of lung cancer cases in ... Recent strides have been made to identify gene mutation ...
Cached Medicine News:Health News:Cancer Survivors Should Take Steps to Keep Healthy During Holidays 2Health News:Guttman, Radley, Reddien, Reiter receive young investigator awards from anatomy society 2Health News:UK researchers present findings from Kentucky breast cancer patients with disease relapse 2Health News:Journal Retracts Faulty Chronic Fatigue Study 2Health News:Journal Retracts Faulty Chronic Fatigue Study 3Health News:Chorus Gives Voice to Those With Alzheimer's 2Health News:Chorus Gives Voice to Those With Alzheimer's 3Health News:Chorus Gives Voice to Those With Alzheimer's 4Health News:Gene fusion in lung cancer afflicting never-smokers may be target for therapy 2
(Date:3/26/2015)... 2015 Huntington Memorial Hospital is the first ... aortic valve replacement (TAVR), a minimally invasive replacement of ... way to replace an aortic valve without a chest ... The procedure is performed by a dedicated ... Alex) Durairaj , MD, interventional cardiologist and Robbin ...
(Date:3/26/2015)... VANCOUVER, British Columbia, March 26, 2015  OncoGenex ... a summary of clinical developments and announced fourth ... Clinical Developments and Anticipated Near-term MilestonesCustirsen ... and Teva agreed to negotiate the termination of ... Negotiations of the final termination agreement are ongoing. ...
(Date:3/26/2015)... -- According to a new market research ... Microwave, Cryoablation, Others), Department (Interventional Radiology, Surgery, Oncology), Application ... Global Forecasts to 2019", published by MarketsandMarkets, the Tumor ... growing at a CAGR of 11.50% by 2019. ... spread through 195 pages and in-depth TOC on "Tumor ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8Tumor Ablation Market Worth $462.0 Million by 2019 2Tumor Ablation Market Worth $462.0 Million by 2019 3Tumor Ablation Market Worth $462.0 Million by 2019 4
... -- Precision Antibody™ announced today its selection by the United ... to influenza virus antigens for both Influenza A and B. ... develop new vaccine potency assays. The term of the monoclonal ... the option of five additional years. On ...
... Robertson Global Health Solutions Corporation (OTCBB: RHSC) and ... they have signed a commercial agreement with Telemedicine Africa ... and solutions to the medically underserved population of Africa ... and Telemedicine Africa aim to deliver RHealth Advisor mobile ...
Cached Medicine Technology:FDA Awards Precision Antibody Contract to Develop Monoclonal Antibodies for Influenza Vaccine Potency Assays 2FDA Awards Precision Antibody Contract to Develop Monoclonal Antibodies for Influenza Vaccine Potency Assays 3Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa 2Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa 3Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa 4
... A unique combination of topography, auto-refraction and ... replaces three devices. The compactness of this ... a perfect space and cost saving ... shortened examination time and easy handling makes ...
The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
World's first commercially available vacuum assisted biopsy device for MRI....
... ultrasound and MRI-guided vacuum assisted breast biopsies ... the patented, FDA-cleared ATEC system for a ... method of breast biopsy. Its compassionate care ... trust YOU.,9 Gauge Handpieces: Useful for biopsy ...
Medicine Products: